Mastek
- P/E
- 10.71
Key Fundamentals
MicrocapIT - SoftwareInformation TechnologyPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 17.70%
- Debt to Equity
- 0.15
- EPS (TTM)
- ₹134.81
- Book Value
- ₹1,028.50
- Market Cap
- —
- P/E (TTM)
- 10.71
- P/B
- 1.40
- ROE
- 15.30%
- Dividend Yield
- 1.65%
- EBITDA
- ₹656 Cr
- 52W High
- ₹2,369.00
- 52W Low
- ₹1,334.20
- Day Range
- ₹1,439.40 – ₹1,474.00
- Volume
- 72,356
Peer Comparison
Information Technology › Computer Software & Consulting › Computers - Software & Consulting
| ₹2,436.00 | 17.08 | ₹8,98,480 Cr | 7.40 | 0.96% | 51.80% | 63.00% | ₹2,83,248 Cr | ₹51,858 Cr | |
| ₹1,128.20 | 14.88 | ₹4,63,085 Cr | 4.86 | 2.26% | 31.90% | 40.00% | ₹1,89,336 Cr | ₹30,788 Cr | |
| ₹1,405.00 | 21.88 | ₹3,89,601 Cr | 5.01 | 3.34% | 23.80% | 30.40% | ₹1,34,374 Cr | ₹17,434 Cr | |
| ₹194.55 | 15.21 | ₹1,94,390 Cr | 2.44 | 1.01% | 15.50% | 17.80% | ₹94,968 Cr | ₹13,285 Cr | |
| ₹1,783.00 | 34.02 | ₹1,76,066 Cr | 5.88 | 0.84% | 17.50% | 23.10% | ₹59,176 Cr | ₹5,163 Cr | |
| ₹4,204.90 | 23.84 | ₹1,26,067 Cr | 4.82 | 0.59% | 23.10% | 29.60% | ₹44,075 Cr | ₹5,197 Cr | |
| ₹6,065.00 | 49.64 | ₹96,188 Cr | 7.82 | 0.66% | 27.20% | 34.40% | ₹15,718 Cr | ₹1,922 Cr | |
| ₹1,443.70 | 10.71 | ₹4,544 Cr | 1.40 | 1.65% | 15.30% | 17.70% | ₹3,769 Cr | ₹417 Cr | |
| Median 8 companies | ₹1,613.35 | 19.48 | ₹1,85,228 Cr | 4.94 | 0.99% | 23.45% | 30.00% | ₹77,072 Cr | ₹9,241 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 63
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 87
- Strong
- Cheap vs sector & own history 24% weight
- Growth
- 24
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 40
- Weak
- Solvency, leverage, coverage 9% weight
- Momentum
- 32
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company has reduced debt.
- Company has been maintaining a healthy dividend payout of 19.0%
- Company's median sales growth is 18.3% of last 10 years
No weaknesses listed
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 3 | 4 |
| Oscillators | Bullish | 2 | 3 | 4 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bullish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 34.70
- Neutral
- MACD (12,26,9)
- −56.49
- Bearish
- SMA (50)
- 1,643.30
- Bearish
- SMA (200)
- 1,691.79
- Bearish
As of
Analyst Rating
4 of 6 analysts rate Buy, 1 Hold, 1 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +21.51% |
|---|---|
| 5Y | +16.52% |
| 3Y | +13.01% |
| 1Y | +7.06% |
| TTM | +5.96% |
Net profit
| 10Y | +39.97% |
|---|---|
| 5Y | +9.90% |
| 3Y | +9.23% |
| 1Y | +7.45% |
| TTM | +5.04% |
Operating cash flow
| 10Y | +32.70% |
|---|---|
| 5Y | +13.56% |
| 3Y | +71.21% |
| 1Y | +36.87% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +12.42 pp |
|---|---|
| 5Y | −5.30 pp |
| 3Y | −1.95 pp |
| 1Y | +0.04 pp |
| TTM | +0.18 pp |
Revenue by year
| Mar 2017 | ₹560 Cr |
|---|---|
| Mar 2018 | ₹817 Cr |
| Mar 2019 | ₹1,033 Cr |
| Mar 2020 | ₹1,071 Cr |
| Mar 2021 | ₹1,722 Cr |
| Mar 2022 | ₹2,184 Cr |
| Mar 2023 | ₹2,563 Cr |
| Mar 2024 | ₹3,055 Cr |
| Mar 2025 | ₹3,455 Cr |
| Mar 2026 | ₹3,699 Cr |
Net profit by year
| Mar 2017 | ₹32.00 Cr |
|---|---|
| Mar 2018 | ₹70.00 Cr |
| Mar 2019 | ₹101 Cr |
| Mar 2020 | ₹114 Cr |
| Mar 2021 | ₹252 Cr |
| Mar 2022 | ₹333 Cr |
| Mar 2023 | ₹310 Cr |
| Mar 2024 | ₹311 Cr |
| Mar 2025 | ₹376 Cr |
| Mar 2026 | ₹404 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Mastek Ltd is a mid-cap IT services company with a market cap of ₹4,955 crore, trading at a PE of 12.5x. FY25 revenue grew 13.1% YoY to ₹3,455 crore with PAT rising 20.9% YoY to ₹376 crore, though Q4FY25 PAT declined 14% YoY despite 16.6% revenue growth. The stock has corrected 36% over the past year, reflecting concerns around margin compression and client concentration.
- FY25 PAT grew 20.9% YoY to ₹375.9 crore, demonstrating strong profit growth despite a challenging IT spending environment
- 12-month order backlog reached $300.4 million, growing 13.5% YoY in USD terms and 24.4% YoY in INR terms, providing revenue visibility
- Compounded sales CAGR of 17% over 5 years and 22% over 10 years reflects consistent top-line execution with median sales growth of 18.3% over 10 years
- UK healthcare vertical (including NHS) grew over 100% YoY in Q4FY25, opening a large addressable market with UK government healthcare budget of £200 billion+
- Company has reduced debt and maintains a healthy dividend payout of 19%, with ₹16 per share final dividend declared for FY25
- Oracle business in North America grew over 50% YoY in FY25, diversifying revenue streams beyond UK government
- Compounded profit CAGR of 16% over 3 and 5 years demonstrates sustained earnings compounding alongside a 16% ROE
- Stock has declined 36% over the past year, significantly underperforming the broader market and IT index, reflecting loss of investor confidence
- Q4FY25 net profit fell 14.1% YoY to ₹81.1 crore despite 16.6% revenue growth, indicating margin pressure with EBITDA margins at 15.3% vs management's 17-19% target range
- Employee count declined from 5,500 to 4,800 (a ~13% reduction) driven by attrition without replacement, raising concerns about delivery capacity for growth
- Healthcare vertical accounts for 22% of revenue with significant NHS England concentration — NHS England's potential restructuring creates client-specific risk
- North America revenue saw an 8% sequential decline in Q4FY25 despite 16% YoY growth, showing volatility in a key growth geography
- TTM revenue growth has decelerated to 7% from 13% 3-year CAGR and 17% 5-year CAGR, suggesting a potential structural slowdown
- UK and Europe account for 45-55% of revenue historically, creating geographic concentration risk tied to UK government IT spending cycles
- 3-year stock CAGR of -6% and 5-year stock CAGR of -6% indicate the market has de-rated the stock despite continued earnings growth, suggesting a possible structural re-rating risk
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Mastek shows steady business development with a notable Middle East IoT win and continued UK public sector strength. No visible headwinds in recent news flow. The company is actively engaging institutional investors ahead of Q1FY27 results on July 21, suggesting confidence in upcoming numbers.
- UK public sector recognition Jul 3
Mastek featured in '100 Years in Monarchy and Democracy' publication for its UK contributions, highlighting a 30+ year partnership with the UK public sector.
- Yanbu Cement digital transformation Jun 29
Mastek partnered with Yanbu Cement to modernise operations using Industrial IoT, improving truck turnaround time by 2x and increasing topline revenue under Saudi Vision 2030.
- Q1FY27 earnings call July 22 Jul 3
Mastek will announce Q1FY27 results on July 21, 2026, with an earnings call scheduled for July 22 at 12:30 PM IST.
- Multiple investor meets late June Jun 25
Mastek scheduled virtual analyst meets with ICICI Securities (June 30, 4 PM), Incred Capital (June 30, 2 PM), and an institutional investor meet on June 25 at 4 PM IST.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 725 | 766 | 784 | 780 | 813 | 867 | 870 | 905 | 915 | 940 | 906 | 938 | 985 | 1,019 |
| Expenses | 598 | 642 | 651 | 655 | 689 | 724 | 729 | 767 | 777 | 795 | 754 | 787 | 834 | 873 |
| Operating Profit | 127 | 123 | 134 | 125 | 124 | 143 | 141 | 139 | 137 | 146 | 152 | 151 | 151 | 146 |
| OPM % | 18% | 16% | 17% | 16% | 15% | 16% | 16% | 15% | 15% | 15% | 17% | 16% | 15% | 14% |
| Other Income | 2 | 1 | 3 | 5 | 4 | 17 | 13 | −5 | 11 | 15 | 14 | 0 | 12 | 22 |
| Interest | 9 | 13 | 13 | 9 | 9 | 11 | 12 | 10 | 9 | 9 | 7 | 7 | 7 | 8 |
| Depreciation | 20 | 21 | 22 | 27 | 20 | 20 | 17 | 19 | 18 | 18 | 18 | 18 | 18 | 19 |
| PBT | 100 | 90 | 102 | 94 | 99 | 129 | 126 | 106 | 121 | 134 | 141 | 125 | 138 | 141 |
| Tax % | 27% | 28% | 24% | −1% | 28% | 0% | 25% | 23% | 24% | 27% | 23% | 15% | 24% | 25% |
| Net Profit | 74 | 65 | 78 | 94 | 72 | 129 | 95 | 81 | 92 | 97 | 108 | 106 | 106 | 106 |
| EPS (₹) | 22.91 | 20.5 | 24.56 | 29.85 | 23.18 | 41.68 | 30.67 | 26.2 | 29.75 | 31.46 | 34.96 | 34.24 | 34.15 | — |
Sep 2026: from the results filed on 23 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,013 | 527 | 560 | 817 | 1,033 | 1,071 | 1,722 | 2,184 | 2,563 | 3,055 | 3,455 | 3,699 | 3,769 |
| Expenses | 965 | 509 | 515 | 718 | 902 | 916 | 1,357 | 1,721 | 2,108 | 2,546 | 2,909 | 3,113 | 3,170 |
| Operating Profit | 47 | 18 | 45 | 100 | 132 | 156 | 364 | 463 | 456 | 509 | 546 | 586 | 600 |
| OPM % | 4.7% | 3.5% | 8% | 12% | 13% | 15% | 21% | 21% | 18% | 17% | 16% | 16% | 16% |
| Other Income | 14 | 15 | 12 | 21 | 25 | 17 | 28 | 36 | 64 | 12 | 30 | 40 | 42 |
| Interest | 1 | 0 | 4 | 6 | 6 | 4 | 8 | 8 | 25 | 44 | 42 | 32 | 30 |
| Depreciation | 37 | 16 | 15 | 19 | 17 | 25 | 45 | 43 | 67 | 90 | 75 | 73 | 73 |
| PBT | 22 | 16 | 39 | 96 | 133 | 144 | 339 | 448 | 427 | 386 | 459 | 521 | 539 |
| Tax % | 20% | 17% | 17% | 27% | 24% | 21% | 26% | 26% | 27% | 19% | 18% | 22% | — |
| Net Profit | 18 | 14 | 32 | 70 | 101 | 114 | 252 | 333 | 310 | 311 | 376 | 404 | 418 |
| EPS (₹) | 7.86 | 5.97 | 13.86 | 29.53 | 42.33 | 44.82 | 82.97 | 98.32 | 95.99 | 97.36 | 122 | 130 | 135 |
| Div. Payout % | 32% | 42% | 25% | 20% | 20% | 18% | 17% | 19% | 20% | 20% | 19% | 18% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 12 | 12 | 12 | 12 | 12 | 13 | 15 | 15 | 15 | 15 | 16 |
| Reserves | 585 | 308 | 457 | 537 | 704 | 778 | 846 | 1,056 | 1,668 | 2,072 | 2,447 | 2,976 |
| Borrowings | 29 | 0 | 66 | 70 | 70 | 335 | 273 | 203 | 404 | 519 | 583 | 438 |
| Other Liabilities | 207 | 108 | 170 | 202 | 179 | 763 | 1,146 | 1,193 | 1,024 | 1,045 | 758 | 863 |
| Total Liabilities | 832 | 428 | 705 | 821 | 966 | 1,888 | 2,277 | 2,467 | 3,111 | 3,652 | 3,803 | 4,293 |
| Fixed Assets | 279 | 66 | 180 | 179 | 167 | 857 | 807 | 841 | 1,740 | 1,950 | 1,818 | 1,938 |
| CWIP | 1 | 0 | 0 | 2 | 1 | 2 | 2 | 4 | 7 | 1 | 2 | 2 |
| Investments | 54 | 50 | 274 | 284 | 396 | 276 | 234 | 66 | 69 | 94 | 178 | 234 |
| Other Assets | 498 | 312 | 251 | 356 | 401 | 754 | 1,235 | 1,556 | 1,296 | 1,607 | 1,805 | 2,119 |
| Total Assets | 832 | 428 | 705 | 821 | 966 | 1,888 | 2,277 | 2,467 | 3,111 | 3,652 | 3,803 | 4,293 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 59 | 32 | 43 | 65 | 75 | 184 | 287 | 273 | 108 | 420 | 396 | 542 |
| Investing | −28 | −84 | −127 | −18 | −54 | −262 | 218 | −26 | −719 | −249 | −260 | 2 |
| Financing | 22 | −4 | 65 | −7 | −16 | 205 | −118 | −128 | 93 | 2 | −57 | −300 |
| Net Cash Flow | 53 | −57 | −20 | 40 | 5 | 127 | 387 | 119 | −519 | 173 | 80 | 244 |
| Free Cash Flow | 10 | 20 | 31 | 50 | 60 | 169 | 276 | 237 | 126 | 391 | 378 | 515 |
| CFO/OP | 121 | 199 | 102 | 74 | 80 | 149 | 92 | 83 | 53 | 104 | 95 | 121 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 48 | 67 | 55 | 78 | 74 | 108 | 79 | 73 | 72 | 67 | 55 | 57 |
| Cash Conversion Cycle | 48 | 67 | 55 | 78 | 74 | 108 | 79 | 73 | 72 | 67 | 55 | 57 |
| Working Capital Days | 25 | 38 | 29 | 15 | 38 | 4 | −35 | −20 | 34 | −1 | 28 | 19 |
| ROCE % | 5% | 3% | 10% | 17% | 19% | 16% | 26% | 32% | 23% | 18% | 17% | 18% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Mastek insights
70 extracted metrics across FY11–FY27.
Documents
- Q1 FY27 concall · Jul 2026Transcript PPT Recording
- Q4 FY26 concall · Apr 2026Transcript PPT Recording
- Q3 FY26 concall · Jan 2026Transcript PPT
- Q2 FY26 concall · Oct 2025PPT
- 5 Mar 2026
- 28 Feb 2025
- 5 Feb 2024
- 2 Mar 2023
- 1 Dec 2020
- General announcements 2 Nov 2026
- General announcements 28 Oct 2026
Frequently Asked Questions about Mastek
What does Mastek Ltd do?
Where is Mastek Ltd (MASTEK) listed?
Which sector does Mastek Ltd belong to?
What is the PE ratio of Mastek Ltd?
What is the 52-week high and low of Mastek Ltd?
Does Mastek Ltd pay dividends?
What is the Return on Equity (ROE) of Mastek Ltd?
Company Information
Established in 1982, Mastek is a provider of vertically-focused enterprise technology solutions. Having its presence in IT industry for almost 4 decades, Mastek Ltd has evolved from an IT solutions provider to Digital transformation partner.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/MASTEK.md for Mastek Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.